[Fundamental Explanation] What is Medical Fee Remuneration? A System with 5,000 Items of Technology and Services, Priced Uniformly – Asahi Shimbun

News Highlights

Medical fee remuneration is a system where the government sets a uniform price for approximately 5,000 items of medical technology and services. It is revised every two years and significantly impacts the management of medical institutions. Understanding this system is essential for establishing medium- to long-term management and business succession strategies. In particular, the scale merits of group formation and the utilization of tax schemes through conversion to specific medical corporations or social medical corporations become key discussion points.

Perspective from M&A Medical Editorial Department

While the Asahi Shimbun’s “Fundamental Explanation” explains the mechanism of medical fee remuneration for the general public, for medical institution managers, especially those considering succession or business expansion due to lack of successors, this “uniform pricing” structure can be a significant factor encouraging consideration of M&A and business succession. For instance, there are many cases where community-based clinics are forced to abandon the introduction of advanced medical equipment due to the heavy burden of capital investment. However, by considering the medical fee remuneration revision cycle (typically every two years) and benefiting from scale merits through group formation or M&A, medical institutions can gain the capacity to invest in maintaining and improving facility standards or providing new revenue-generating services. Furthermore, schemes that consider transitioning to specific medical corporations or social medical corporations can be effective options for facilitating future succession while receiving tax preferential treatment. Understanding the medical fee remuneration system is not merely about cost management; it forms the foundation for considering business growth and succession strategies in an integrated manner.

Discussion Points Indicated by This News

• The “uniform pricing” of medical fee remuneration can create disparities in the profitability of individual medical institutions, serving as a motive for M&A and business succession.
• The necessity of medium- to long-term management and succession strategies based on the biennial medical fee remuneration revision cycle.
• The potential for scale merits through group formation to contribute to maintaining facility standards and distributing the burden of capital investment.
• The point that transitioning to specific medical corporations or social medical corporations can lead to smoother business succession with tax schemes.

Practical Questions Arising from This News

• How might my institution’s revenue specifically change with a medical fee remuneration revision?
• If group formation occurs, how are the “facility standards” for medical fee remuneration handled?
• What specific tax benefits are associated with transitioning to specific medical corporations, etc.?

If You Feel “Should I Consult Too?”

Many managers and successors likely feel a vague sense of anxiety about the medical fee remuneration system, particularly how the biennial revisions impact their institution’s management. If you find yourself repeatedly facing uncertainty about future revenue with each revision, or if you are unable to proceed with new capital investments or service development, this may be a sign that you should consider options such as business expansion/group formation through M&A or business succession, or a change in corporate status. Consulting with experts may reveal concrete paths suited to your institution’s current situation and future vision.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, operating on a complete success fee basis. We handle consultations with strict confidentiality. Free consultation here